Add to watchlist
$115.83
Last updated:06/15/2021
ABBV: NYSE
AbbVie Inc

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK … Show more

Dividend yield
4.28%
$4.96 anually

3y growth is 14.66%– Yield is 91% higher than average in Health Care sector

P/E ratio
39.76x
vs. 9.29x forward

Price is 39.76x times more than EPS $2.91 which eaquals $115.83

Payout ratio
170.27%
Yearly

170.27% of earnings is used as dividends.

CASH payout ratio

Last quarter

Become our supporter to unlock all data!
Stock volatility (Beta)
past 12 months

Become our supporter to unlock all data!
ABBV dividends
Payout frequency
Quarterly
Latest ex-date
04/14/2021
3y growth
14.66%
5y growth
21.76%
$0.71
$0.71
01/11/2018
$0.96
$0.96
04/12/2018
$0.96
$0.96
07/12/2018
$0.96
$0.96
10/12/2018
2018
$3.59
$1.07
$1.07
01/14/2019
$1.07
$1.07
04/12/2019
$1.07
$1.07
07/12/2019
$1.07
$1.07
10/11/2019
2019
$4.28
$1.18
$1.18
01/14/2020
$1.18
$1.18
04/14/2020
$1.18
$1.18
07/14/2020
$1.18
$1.18
10/14/2020
2020
$4.72
$1.3
$1.3
01/14/2021
$1.3
$1.3
04/14/2021
2021
So far
$2.6
Company results
Quarterly
Annual
Fundamentals
2017
2018
2019
2020
Net Income
Income minus expenses, depreciation, interest, taxes, and other expenses
5.309B
5.687B
+7.12%
7.882B
+38.60%
4.622B
-41.36%
Cashflow
Sum up money going in and out company
9.96B
13.427B
+34.81%
13.324B
-0.77%
17.588B
+32.00%
Total liabilities
All combined debts and obligations
65.689B
67.798B
+3.21%
97.287B
+43.50%
137.468B
+41.30%
Stock exposure in ETFs
ETF
Percentage of ETF
Become a premium member and see all 101 ETFs that include this stock
Company profile
CEO
Mr. Richard A. Gonzalez
Market capitalization
Mega (203.82B)
ABBV price history
Loading price stock history...